LC/MS versus Immune-Based Bioanalytical Methods in Quantitation of Therapeutic Biologics in Biological Matrices-Reference-Cited by-同舟云学术

LC/MS versus Immune-Based Bioanalytical Methods in Quantitation of Therapeutic Biologics in Biological Matrices

Published:2015-12-30 Issue: Volume: Page:1-17
ISSN:
Container-title:Pharmaceutical Sciences Encyclopedia
language:
Short-container-title:

Author:

An Bo¹,Zhang Ming¹,Qu Jun¹

Affiliation:

1. State University of New York at Buffalo; Buffalo NY USA

Publisher

John Wiley & Sons, Inc.

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/9780470571224.pse556/fullpdf

Reference121 articles.

1. Characterization of critical reagents in ligand-binding assays: enabling robust bioanalytical methods and lifecycle management;Geist;Bioanalysis,2013

2. Unique challenges of providing bioanalytical support for biological therapeutic pharmacokinetic programs;Nowatzke;Bioanalysis,2011

3. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes;Engvall;J Immunol,1972

4. Challenges in selectivity, specificity and quantitation range of ligand-binding assays: case studies using a microfluidics platform;Yang;Bioanalysis,2014

5. Application and challenges in using LC-MS assays for absolute quantitative analysis of therapeutic proteins in drug discovery;Zheng;Bioanalysis,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the pharmacokinetic journey of Fc-fusion protein, rhIL-7-hyFc using complementary approach of two analytical methods, accelerator mass spectrometry and ELISA;Antibody Therapeutics;2024-02-06

2. Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership Meeting;mAbs;2021-01-01